# Chloroquine, Hydroxychloroquine or Only Supportive Care in Patients AdmItted With Moderate to Severe COVID-19

> **NCT04362332** · PHASE4 · TERMINATED · sponsor: **UMC Utrecht** · enrollment: 25 (actual)

## Conditions studied

- COVID-19

## Interventions

- **DRUG:** Chloroquine Sulfate
- **DRUG:** Hydroxychloroquine
- **OTHER:** Standard supportive care

## Key facts

- **NCT ID:** NCT04362332
- **Lead sponsor:** UMC Utrecht
- **Sponsor class:** OTHER
- **Phase:** PHASE4
- **Study type:** INTERVENTIONAL
- **Status:** TERMINATED
- **Start date:** 2020-04-14
- **Primary completion:** 2020-06-08
- **Final completion:** 2020-06-08
- **Target enrollment:** 25 (ACTUAL)
- **Why stopped:** Currently, almost no patients admitted to Dutch hospitals. If any effect of HCQ is to be expected we need more than 1000 inclusions
- **Last updated:** 2020-06-19

## Collaborators

- [object Object]

## Primary source

ClinicalTrials.gov registry: https://clinicaltrials.gov/study/NCT04362332

## Citation

> US National Library of Medicine, ClinicalTrials.gov registration NCT04362332, "Chloroquine, Hydroxychloroquine or Only Supportive Care in Patients AdmItted With Moderate to Severe COVID-19". Retrieved via AI Analytics 2026-06-25 from https://api.ai-analytics.org/clinical/NCT04362332. Licensed CC0.

---

*[Clinical trials dataset](/datasets/clinical-trials) · CC0 1.0*